TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 98 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $782,000 | -1.3% | 47,760 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $792,000 | -11.4% | 48,025 | -1.9% | 0.00% | 0.0% |
| Q1 2021 | $894,000 | -6.6% | 48,956 | -6.9% | 0.00% | 0.0% |
| Q4 2020 | $957,000 | +6.1% | 52,572 | +4.0% | 0.00% | 0.0% |
| Q3 2020 | $902,000 | -92.2% | 50,571 | -92.2% | 0.00% | -94.1% |
| Q2 2020 | $11,611,000 | +8.7% | 647,564 | -8.0% | 0.02% | -5.6% |
| Q1 2020 | $10,684,000 | -25.6% | 703,852 | -3.3% | 0.02% | -14.3% |
| Q4 2019 | $14,363,000 | +29.1% | 727,975 | +12.5% | 0.02% | +23.5% |
| Q3 2019 | $11,129,000 | +18.4% | 647,025 | +21.8% | 0.02% | +21.4% |
| Q2 2019 | $9,400,000 | -22.8% | 531,093 | -11.1% | 0.01% | -26.3% |
| Q1 2019 | $12,173,000 | +271.8% | 597,600 | +370.9% | 0.02% | +216.7% |
| Q4 2018 | $3,274,000 | – | 126,895 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |